Abstract
A 34 year old woman with pulmonary tuberculosis started first-line anti-tuberculosis therapy comprising rifampicin, isoniazid, pyrazinamide, and etham......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
